Fisher & Paykel Healthcare - FSPKF Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$18.06
▲ +0.11 (0.61%)

This chart shows the closing price for FSPKF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Fisher & Paykel Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FSPKF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FSPKF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Fisher & Paykel Healthcare in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $18.06.

This chart shows the closing price for FSPKF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in Fisher & Paykel Healthcare. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/30/2023Royal Bank of CanadaUpgradeUnderperform ➝ Sector Perform
1/23/2023CitigroupDowngradeBuy ➝ Neutral
12/21/2022Royal Bank of CanadaInitiated CoverageUnderperform
11/17/2022The Goldman Sachs GroupUpgradeNeutral ➝ Conviction-Buy
11/16/2022Morgan StanleyInitiated CoverageOverweight
5/6/2022CitigroupUpgradeNeutral ➝ Buy
11/25/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$31.10
5/25/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
(Data available from 6/24/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Fisher & Paykel Healthcare logo
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Read More

Today's Range

Now: $18.06
Low: $18.06
High: $18.51

50 Day Range

MA: $16.70
Low: $15.64
High: $18.17

52 Week Range

Now: $18.06
Low: $12.00
High: $18.51

Volume

2,800 shs

Average Volume

2,476 shs

Market Capitalization

N/A

P/E Ratio

106.46

Dividend Yield

2.29%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Fisher & Paykel Healthcare?

The following equities research analysts have issued reports on Fisher & Paykel Healthcare in the last twelve months: Royal Bank of Canada.
View the latest analyst ratings for FSPKF.

What is the current price target for Fisher & Paykel Healthcare?

0 Wall Street analysts have set twelve-month price targets for Fisher & Paykel Healthcare in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Fisher & Paykel Healthcare in the next year.
View the latest price targets for FSPKF.

What is the current consensus analyst rating for Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in FSPKF, but not buy more shares or sell existing shares.
View the latest ratings for FSPKF.

What other companies compete with Fisher & Paykel Healthcare?

How do I contact Fisher & Paykel Healthcare's investor relations team?

Fisher & Paykel Healthcare's physical mailing address is 15 Maurice Paykel Place, Auckland, 2013. The company's listed phone number is (649) 574-0100. The official website for Fisher & Paykel Healthcare is www.fphcare.com. Learn More about contacing Fisher & Paykel Healthcare investor relations.